西维斯健康CVS Health（CVS）2025年第三季度业绩报告「NYSE」（英文版）（25页）.pdf

1、 Exhibit 99.1 CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE Financial Highlights Third quarter total revenues increased to a record high$102.9 billion,up 7.8%compared to prior yearThird quarter GAAP diluted loss per share of$3.13,inclusive of a$5.7 bil

2、lion goodwill impairment charge relatedto the Health Care Delivery reporting unitThird quarter Adjusted EPS of$1.60Generated year-to-date cash flow from operations of$7.2 billionOperational Highlights Aetna receives industry-leading Medicare Advantage Star Ratings resultsLaunch of annual vaccination

3、 campaign at CVS Pharmacy and MinuteClinic locations nationwideCaremark closes out another strong selling season with contract wins totaling nearly$6.0 billion and retention inthe high nineties,highlighting commitment to providing exceptional value and transparency2025 Full-Year Guidance Updated GAA

4、P diluted earnings(loss)per share guidance range to$(0.34)to$(0.24)from$3.84 to$3.94Raised Adjusted EPS guidance range to$6.55 to$6.65 from$6.30 to$6.40Updated cash flow from operations guidance to a range of$7.5 billion to$8.0 billion from at least$7.5 billionCEO Commentary“CVS Health uniquely deli

5、vers what the people we serve want the most:a connected,simpler experience that improves health and simplifies care.Our leadership team has stabilized operations and is focused on businesses and markets where we can succeed.As a result,we are making progress on our journey to be Americas most truste

6、d health care company.Our strong Enterprise performance demonstrates the continued focus we have on operational and financial improvement across our businesses.”David Joyner,CVS Health President and CEOWOONSOCKET,RHODE ISLAND,October 29,2025 -CVS Health Corporation (NYSE:CVS)today announced operatin